Iavarone, Massimo; Invernizzi, Federica; Ivanics, Tommy et al.
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyLIVER TRANSPLANTATION. Bd. 27. H. 12. 2021 S. 1767-1778
Ascher, Stefanie; Wilms, Eivor; Pontarollo, Giulia et al.
Response by Ascher et al to Letter Regarding Article, "Gut Microbiota Restricts NETosis in Acute Mesenteric Ischemia-Reperfusion Injury"ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Bd. 41. H. 1. 2021 S. E74-E75
Kahaly, George J.; Bartalena, Luigi
Response to comment by Smith on the 2021 EUGOGO guidelinesEUROPEAN JOURNAL OF ENDOCRINOLOGY. Bd. 185. H. 6. 2021 S. L15-L16
Lang, Hauke; Kloth, Michael; Moehler, Markus et al.
Response to the Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases''ANNALS OF SURGERY. Bd. 274. H. 6. 2021 S. E714-E714
Kim, Richard D.; Harris, William P.; Sung, Max W. et al.
Results of a phase Ib study of regorafenib (REG) 80 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021
Adenugba, Akinbami; Hornung, Matthias; Weigand, Kilian et al.
Ribavirin Improves NK Cell IFN gamma Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant RecipientsTRANSPLANTATION. Bd. 105. H. 10. 2021 S. 2226-2238
Kaps, Leonard; Hildebrand, Katharina; Nagel, Michael et al.
Risk factors for poorer health literacy in patients with liver cirrhosisPLOS ONE. Bd. 16. H. 7. 2021
Boedecker, Simone Cosima; Weinmann-Menke, Julia
Role of nutrition in immune-related kidney diseasesNEPHROLOGE. Bd. 16. H. 4. 2021 S. 224-228
Kluge, S.; Janssens, U.; Welte, T. et al.
S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19PNEUMOLOGIE. 2021
Cornberg, Markus; Sandmann, Lisa; Protzer, Ulrike et al.
S3 Guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) for the Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection (AWMF Register No. 021-11)ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 59. H. 07. 2021 S. 691-776